Cargando…
Why lithium studies for ALS treatment should not be halted prematurely
Autores principales: | Agam, Galila, Israelson, Adrian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151332/ https://www.ncbi.nlm.nih.gov/pubmed/25228854 http://dx.doi.org/10.3389/fnins.2014.00267 |
Ejemplares similares
-
The observed alteration in BCL2 expression following lithium treatment is influenced by the choice of normalization method
por: Odeya, Damri, et al.
Publicado: (2018) -
Is There Justification to Treat Neurodegenerative Disorders by Repurposing Drugs? The Case of Alzheimer’s Disease, Lithium, and Autophagy
por: Damri, Odeya, et al.
Publicado: (2020) -
Low-Dose Aspirin Augments the Anti-Inflammatory Effects of Low-Dose Lithium in Lipopolysaccharide-Treated Rats
por: Shvartsur, Rachel, et al.
Publicado: (2022) -
Lithium Treatment Is Safe in Children With Intellectual Disability
por: Yuan, Junying, et al.
Publicado: (2018) -
Honokiol Inhibits HIF-1α-Mediated Glycolysis to Halt Breast Cancer Growth
por: Yi, Xianglan, et al.
Publicado: (2022)